Portal Login:
  • Clients
  • Providers
  • Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
    Portal Login:
  • Clients
  • Providers
  • About MCN
  • Careers
  • MCNTalk
  • Contact Us

MCN | Medical Consultants Network

The Power of a Second Look

  • Services
    • Independent Medical Examinations
    • Medical Peer Reviews
    • Bill Review Services
    • Utilization Reviews
  • Expertise
    • Short and Long-Term Disability
    • Workers’ Compensation
    • Auto/PIP/Casualty/Liability
    • Independent Review Organization Services
  • For Clients
  • For Providers
  • Your Exam
    • About Your Exam
    • About Your External Review
    • Contact & Scheduling
  • Schedule Now
  • About MCN
  • MCNTalk
  • Careers
  • Contact Us

MCNTalk
News, Insights & Opinions

Home / MCNTalk / Charges Brought Against Executives Aggressively Pushing Pain...

December 15, 2016

Charges Brought Against Executives Aggressively Pushing Pain Drug Fentanyl

Small Arizona drug company Insys Therapeutics is back in the news due to the roles that several former executives played in a scheme that involved aggressive sales of the highly addictive pain drug fentanyl.  Although criminal charges are unusual in cases involving pharmaceutical companies, federal prosecutors have brought racketeering charges against the executives. “Patient safety is paramount, and prescriptions for these highly addictive drugs, especially fentanyl, which is among the most potent and addictive opioids, should be prescribed without the influence of corporate money,” said Carmen M. Ortiz, the United States attorney in Massachusetts. Prosecutors hope these charges send a clear message to pharmaceutical companies that they will continue to battle the opioid crisis by any means necessary. See the New York Times article here.

The social cost of this behavior is profound. Not only is this behavior criminal, but so is that of those physicians whom the company pandered to, some of whom have also been prosecuted. Today’s burgeoning heroin epidemic is in part fueled by addicts who are made so by improper and dead-wrong prescribing of opiates for chronic pain.

Over the past year we have shared a few articles on this blog about Insys Therapeutics and the drug fentanyl. If you are interested in a more thorough account of both the drug and the company, you can check them out here:

Desperate and Dangerous Measures to Increase Drug Sales

A Further Look at Insys Therapeutics and the Dangers of Fentanyl

Fentanyl Penetrating Illegal Drug Markets in the United States

 

 

Share this:

  • Twitter
  • Email
  • More
  • Facebook
  • Reddit
  • Print

Leave a Comment

Previous Post
Next Post

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • The Quality Divide: What Makes a Quality IME Physician?
  • The Quality Divide: Is Your Vendor Driving IME Excellence?
  • The Quality Divide: When and How to Request an IME?
  • April Clinic Calendars Are Available
  • MCN’s Client Portal Login Page is Changing

Archives

Footer


  • Twitter
  • LinkedIn

Quick Links

  • Services
  • Expertise
  • About MCN
  • Careers

Division Headquarters

MCN
1200 5th Ave., Ste. 650
Seattle, WA 98101

See all offices

Email Us

General Inquiries: info@mcn.com
Sales & Marketing: marketing@mcn.com

Call Us

206.343.6100
800.248.6269

© Copyright 2023 Mitchell International, Inc. All Rights Reserved.

  • Privacy Policy
  • Sitemap